Growth Metrics

Merck (MRK) Other Non-Current Assets (2016 - 2026)

Merck has reported Other Non-Current Assets over the past 16 years, most recently at $19.8 billion for Q1 2026.

  • Quarterly Other Non-Current Assets rose 18.12% to $19.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $19.8 billion through Mar 2026, up 18.12% year-over-year, with the annual reading at $18.8 billion for FY2025, 17.29% up from the prior year.
  • Other Non-Current Assets was $19.8 billion for Q1 2026 at Merck, up from $18.8 billion in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $19.8 billion in Q1 2026 and troughed at $4.0 million in Q2 2022.
  • The 5-year median for Other Non-Current Assets is $13.6 billion (2024), against an average of $12.8 billion.
  • Year-over-year, Other Non-Current Assets skyrocketed 18308.7% in 2024 and then grew 17.29% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $9.5 billion in 2022, then rose by 25.9% to $12.0 billion in 2023, then surged by 33.74% to $16.0 billion in 2024, then grew by 17.29% to $18.8 billion in 2025, then increased by 5.25% to $19.8 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Other Non-Current Assets are $19.8 billion (Q1 2026), $18.8 billion (Q4 2025), and $18.3 billion (Q3 2025).